Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-24-012068

Options or other derivatives

  • Executive Chairman acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
ARMEN GARO H Executive Chairman 2024-03-25 Grant or award · PTIX Common stock Options +250,000 $1.74 $435,000 250,000 D
Loading xslF345X05/ownership.xml…